News
04-24-2013, 03:20 AM
Researchers at Karolinska Institutet in Sweden have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, which appears white on a mammogram, during treatment...
More... (http://www.medicalnewstoday.com/releases/259541.php)
More... (http://www.medicalnewstoday.com/releases/259541.php)